| Item Type | Name |
|
Academic Article
|
LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications.
|
|
Academic Article
|
LOX-1: a new target for therapy for cardiovascular diseases.
|
|
Academic Article
|
LOX-1 and obesity.
|
|
Academic Article
|
Racial disparities in prescriptions for cardioprotective drugs and cardiac outcomes in Veterans Affairs Hospitals.
|
|
Academic Article
|
Novel concepts in the genesis of hypertension: role of LOX-1.
|
|
Academic Article
|
Oxidized LDL, LOX-1 and atherosclerosis.
|
|
Academic Article
|
Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation.
|
|
Academic Article
|
Do atherosclerosis and obesity-associated susceptibility to cancer share causative link to oxLDL and LOX-1?
|
|
Academic Article
|
Angiogenesis is a link between atherosclerosis and tumorigenesis: role of LOX-1.
|
|
Academic Article
|
LOX-1 and angiotensin receptors, and their interplay.
|
|
Academic Article
|
LOX-1: a critical player in the genesis and progression of myocardial ischemia.
|
|
Academic Article
|
LOX-1 transcription.
|
|
Concept
|
Antibiotics, Antineoplastic
|
|
Concept
|
Adenosine Diphosphate
|
|
Concept
|
Ethanol
|
|
Concept
|
Antigens, Surface
|
|
Concept
|
Androgens
|
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
|
Concept
|
Angiotensins
|
|
Concept
|
beta-Galactosidase
|
|
Concept
|
Antiviral Agents
|
|
Concept
|
Adrenergic beta-Agonists
|
|
Concept
|
Antigens, Neoplasm
|
|
Concept
|
Amino Acid Chloromethyl Ketones
|
|
Concept
|
Angiotensin III
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Apolipoproteins E
|
|
Concept
|
Biphenyl Compounds
|
|
Concept
|
Antithrombins
|
|
Concept
|
Collagen
|
|
Concept
|
Curcumin
|
|
Concept
|
Bromocriptine
|
|
Concept
|
Creatinine
|
|
Concept
|
Flavonoids
|
|
Concept
|
Actins
|
|
Concept
|
Angiotensin II
|
|
Concept
|
Anti-Infective Agents
|
|
Concept
|
Benzimidazoles
|
|
Concept
|
Amiodarone
|
|
Concept
|
Anti-Bacterial Agents
|
|
Concept
|
Antibodies
|
|
Concept
|
Dactinomycin
|
|
Concept
|
Contrast Media
|
|
Concept
|
Hypolipidemic Agents
|
|
Concept
|
Antineoplastic Agents, Phytogenic
|
|
Concept
|
Angiotensin-Converting Enzyme Inhibitors
|
|
Concept
|
Anticoagulants
|
|
Concept
|
Epitopes
|
|
Concept
|
Antioxidants
|
|
Concept
|
Angiotensin I
|
|
Concept
|
Anions
|
|
Concept
|
Antibodies, Anti-Idiotypic
|
|
Concept
|
Antihypertensive Agents
|
|
Concept
|
Anti-Arrhythmia Agents
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Anti-Inflammatory Agents
|
|
Concept
|
Adrenergic beta-Antagonists
|
|
Concept
|
Aldehydes
|
|
Concept
|
Anticholesteremic Agents
|
|
Concept
|
Acetophenones
|
|
Concept
|
Aldehyde Dehydrogenase
|
|
Concept
|
Autoantigens
|
|
Concept
|
Benzhydryl Compounds
|
|
Concept
|
Cardiotonic Agents
|
|
Concept
|
Carbocyanines
|
|
Concept
|
Fatty Acids
|
|
Concept
|
Calcium-Binding Proteins
|
|
Concept
|
Cardiovascular Agents
|
|
Concept
|
Cannabis
|
|
Concept
|
Microtubule-Associated Proteins
|
|
Concept
|
Dietary Fats, Unsaturated
|
|
Concept
|
Drug Combinations
|
|
Concept
|
Central Nervous System Depressants
|
|
Concept
|
Cholesterol
|
|
Concept
|
Aspirin
|
|
Concept
|
Hydrogen Peroxide
|
|
Concept
|
Calcium Channel Blockers
|
|
Concept
|
Carrier Proteins
|
|
Concept
|
C-Reactive Protein
|
|
Concept
|
Catecholamines
|
|
Concept
|
Atenolol
|
|
Concept
|
Binding Sites
|
|
Concept
|
Cannabinoids
|
|
Concept
|
Chromans
|
|
Concept
|
Genetic Vectors
|
|
Concept
|
Colchicine
|
|
Concept
|
Base Sequence
|
|
Concept
|
Heparin
|
|
Concept
|
Dietary Carbohydrates
|
|
Concept
|
Catalase
|
|
Concept
|
Hormones
|
|
Concept
|
Isoproterenol
|
|
Concept
|
Doxorubicin
|
|
Concept
|
Diclofenac
|
|
Concept
|
L-Lactate Dehydrogenase
|
|
Concept
|
Laminin
|
|
Concept
|
Drug Carriers
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Thioglycolates
|
|
Concept
|
Transcription Factors
|
|
Concept
|
DNA-Binding Proteins
|
|
Concept
|
Calpain
|
|
Concept
|
Fluorescent Dyes
|
|
Concept
|
Ephedrine
|
|
Concept
|
Estrogens
|
|
Concept
|
Heptanoic Acids
|
|
Concept
|
Nitroglycerin
|
|
Concept
|
Protein Kinase C
|
|
Concept
|
DNA, Mitochondrial
|
|
Concept
|
Fibrinogen
|
|
Concept
|
Interferon-gamma
|
|
Concept
|
Plasminogen Activator Inhibitor 1
|
|
Concept
|
Imines
|
|
Concept
|
Polyethylene Glycols
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Pyrimidines
|
|
Concept
|
Serine
|
|
Concept
|
Salicylates
|
|
Concept
|
Cholesterol, LDL
|
|
Concept
|
Milk Proteins
|
|
Concept
|
Lipoproteins
|
|
Concept
|
Membrane Proteins
|
|
Concept
|
Membrane Glycoproteins
|
|
Concept
|
Sulfones
|
|
Concept
|
Oxygen
|
|
Concept
|
Plasmids
|
|
Concept
|
Caspases
|
|
Concept
|
Oligoribonucleotides, Antisense
|
|
Concept
|
Triazoles
|
|
Concept
|
Growth Inhibitors
|
|
Concept
|
Warfarin
|
|
Concept
|
Histocompatibility Antigens Class I
|
|
Concept
|
Receptors, Immunologic
|
|
Concept
|
RNA, Viral
|
|
Concept
|
Protein Subunits
|
|
Concept
|
Vascular Cell Adhesion Molecule-1
|
|
Concept
|
Lipoproteins, LDL
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Organometallic Compounds
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Oxidants
|
|
Concept
|
Lipoprotein(a)
|
|
Concept
|
Indium Radioisotopes
|
|
Concept
|
Triglycerides
|
|
Concept
|
Receptors, Glucagon
|
|
Concept
|
ATP-Binding Cassette Transporters
|
|
Concept
|
Proteins
|
|
Concept
|
Superoxide Dismutase
|
|
Concept
|
Calcium
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Liposomes
|
|
Concept
|
NADP
|
|
Concept
|
Nitric Oxide
|
|
Concept
|
Polysaccharide-Lyases
|
|
Concept
|
Proto-Oncogene Proteins
|
|
Concept
|
Tissue Plasminogen Activator
|
|
Concept
|
Chemokine CCL2
|
|
Concept
|
Cytochromes c
|
|
Concept
|
Toll-Like Receptor 9
|
|
Concept
|
Peptide Fragments
|
|
Concept
|
Progestins
|
|
Concept
|
Pyrazines
|
|
Concept
|
Oncogene Proteins
|
|
Concept
|
Platelet Glycoprotein GPIIb-IIIa Complex
|
|
Concept
|
Cell Adhesion Molecules
|
|
Concept
|
Alternative Splicing
|
|
Concept
|
Tyrosine
|
|
Concept
|
Antigens, Differentiation, Myelomonocytic
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-3
|
|
Concept
|
Radiopharmaceuticals
|
|
Concept
|
Toll-Like Receptor 4
|
|
Concept
|
Cyclooxygenase 2
|
|
Concept
|
Myeloid Differentiation Factor 88
|
|
Concept
|
Recombinant Proteins
|
|
Concept
|
Calcineurin
|
|
Concept
|
Natriuretic Peptide, Brain
|
|
Concept
|
Apoptosis Inducing Factor
|
|
Concept
|
Tetradecanoylphorbol Acetate
|
|
Concept
|
Valine
|
|
Concept
|
Decorin
|
|
Concept
|
Annexin A5
|
|
Concept
|
Heparan Sulfate Proteoglycans
|
|
Concept
|
Granulocyte Colony-Stimulating Factor
|
|
Concept
|
Skin, Artificial
|
|
Concept
|
Heme Oxygenase-1
|
|
Concept
|
Receptors, Notch
|
|
Concept
|
Inhibitor of Apoptosis Proteins
|
|
Concept
|
Cyclooxygenase 2 Inhibitors
|
|
Concept
|
Nicotinamide Phosphoribosyltransferase
|
|
Concept
|
Endothelin-1
|
|
Concept
|
Platelet Aggregation Inhibitors
|
|
Concept
|
Mitochondrial Proteins
|
|
Concept
|
Capsid Proteins
|
|
Concept
|
Fibronectins
|
|
Concept
|
Homocysteine
|
|
Concept
|
Fish Oils
|
|
Concept
|
Gadolinium
|
|
Concept
|
Proteoglycans
|
|
Concept
|
Free Radicals
|
|
Concept
|
Dietary Proteins
|
|
Concept
|
DNA
|
|
Concept
|
Fluorobenzenes
|
|
Concept
|
Hydroxycholesterols
|
|
Concept
|
Lipopolysaccharides
|
|
Concept
|
Cholesterol, HDL
|
|
Concept
|
Muscle Proteins
|
|
Concept
|
NAD
|
|
Concept
|
Receptors, LDL
|
|
Concept
|
Tetrazoles
|
|
Concept
|
Troponin
|
|
Concept
|
Aspartic Acid Endopeptidases
|
|
Concept
|
NF-kappa B
|
|
Concept
|
Culture Media, Conditioned
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
Metalloproteases
|
|
Concept
|
PPAR gamma
|
|
Concept
|
Catenins
|
|
Concept
|
Prolactin
|
|
Concept
|
Pyrroles
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Sodium Chloride
|
|
Concept
|
Thromboxane A2
|
|
Concept
|
Serine Proteinase Inhibitors
|
|
Concept
|
Proto-Oncogene Proteins c-jun
|
|
Concept
|
Urotensins
|
|
Concept
|
Paclitaxel
|
|
Concept
|
DEAD-box RNA Helicases
|
|
Concept
|
Receptor, Angiotensin, Type 1
|
|
Concept
|
Angiotensin II Type 1 Receptor Blockers
|
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
|
Concept
|
Tumor Suppressor Protein p53
|
|
Concept
|
Erythropoietin
|
|
Concept
|
Transcription Factor AP-1
|
|
Concept
|
Core Binding Factors
|
|
Concept
|
Receptors, Scavenger
|
|
Concept
|
Osteopontin
|
|
Concept
|
Proprotein Convertases
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
PTEN Phosphohydrolase
|
|
Concept
|
DNA Primers
|
|
Concept
|
Onium Compounds
|
|
Concept
|
Succinimides
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p21
|
|
Concept
|
bcl-X Protein
|
|
Concept
|
Creatine Kinase, MB Form
|
|
Concept
|
Glucose
|
|
Concept
|
Small Molecule Libraries
|
|
Concept
|
Dipeptidyl-Peptidase IV Inhibitors
|
|
Concept
|
Apoptosis Regulatory Proteins
|
|
Concept
|
Sodium-Glucose Transporter 1
|
|
Concept
|
Nitric Oxide Synthase Type I
|
|
Concept
|
Vitamin E
|
|
Concept
|
Receptors, Transforming Growth Factor beta
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Interleukin-4
|
|
Concept
|
Receptors, Cytoplasmic and Nuclear
|
|
Concept
|
Inflammation Mediators
|
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
|
Concept
|
HSP72 Heat-Shock Proteins
|
|
Concept
|
Receptors, Oxidized LDL
|
|
Concept
|
Dosage Forms
|
|
Concept
|
Epinephrine
|
|
Concept
|
Blood Glucose
|
|
Concept
|
Plant Preparations
|
|
Concept
|
Incretins
|
|
Concept
|
Simvastatin
|
|
Concept
|
Glucosides
|
|
Concept
|
Gold
|
|
Concept
|
Insulin
|
|
Concept
|
Cytochrome b Group
|
|
Concept
|
Docosahexaenoic Acids
|
|
Concept
|
Flavoproteins
|
|
Concept
|
Lactones
|
|
Concept
|
Molsidomine
|
|
Concept
|
Atrial Natriuretic Factor
|
|
Concept
|
Viral Proteins
|
|
Concept
|
Adiponectin
|
|
Concept
|
Extracellular Signal-Regulated MAP Kinases
|
|
Concept
|
Endodeoxyribonucleases
|
|
Concept
|
Glucagon-Like Peptide 1
|
|
Concept
|
Receptor, Angiotensin, Type 2
|
|
Concept
|
Matrix Metalloproteinase 3
|
|
Concept
|
Nucleic Acid Synthesis Inhibitors
|
|
Concept
|
Sirolimus
|
|
Concept
|
Scavenger Receptors, Class E
|
|
Concept
|
Glycosides
|
|
Concept
|
Hypoxia-Inducible Factor 1, alpha Subunit
|
|
Concept
|
Interleukin-1beta
|
|
Concept
|
Ligands
|
|
Concept
|
Fluoresceins
|
|
Concept
|
Gout Suppressants
|
|
Concept
|
Immunologic Factors
|
|
Concept
|
Cholesterol, Dietary
|
|
Concept
|
Imidazoles
|
|
Concept
|
Immunosuppressive Agents
|
|
Concept
|
Connective Tissue Growth Factor
|
|
Concept
|
Insulin-Like Growth Factor I
|
|
Concept
|
Indomethacin
|
|
Concept
|
Hypoglycemic Agents
|
|
Concept
|
Malondialdehyde
|
|
Concept
|
Epoprostenol
|
|
Concept
|
Metalloendopeptidases
|
|
Concept
|
Metformin
|
|
Concept
|
Peptidyl-Dipeptidase A
|
|
Concept
|
Lipids
|
|
Concept
|
Norepinephrine
|
|
Concept
|
Heat-Shock Proteins
|
|
Concept
|
Immunoglobulin G
|
|
Concept
|
Nitriles
|
|
Concept
|
Oligopeptides
|
|
Concept
|
Oxidoreductases
|
|
Concept
|
Vasoconstrictor Agents
|
|
Concept
|
Nitric Oxide Synthase Type II
|
|
Concept
|
Thalidomide
|
|
Concept
|
Polyisoprenyl Phosphates
|
|
Concept
|
Vitamins
|
|
Concept
|
Pyrazoles
|
|
Concept
|
Pyridines
|
|
Concept
|
Phospholipids
|
|
Concept
|
Polyurethanes
|
|
Concept
|
Superoxides
|
|
Concept
|
Phosphatidylinositol 3-Kinases
|
|
Concept
|
Extracellular Matrix Proteins
|
|
Concept
|
Thrombomodulin
|
|
Concept
|
Uric Acid
|
|
Concept
|
RNA, Untranslated
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Receptors, Angiotensin
|
|
Concept
|
Coated Materials, Biocompatible
|
|
Concept
|
Fatty Acids, Omega-3
|
|
Concept
|
Cysteine Proteinase Inhibitors
|
|
Concept
|
Collagen Type I
|
|
Concept
|
Thiamine
|
|
Concept
|
Receptors, Estrogen
|
|
Concept
|
Intracellular Signaling Peptides and Proteins
|
|
Concept
|
Collagenases
|
|
Concept
|
Sodium Salicylate
|
|
Concept
|
Protein Kinase C-alpha
|
|
Concept
|
Prostate-Specific Antigen
|
|
Concept
|
Anti-Allergic Agents
|
|
Concept
|
Anthracyclines
|
|
Concept
|
Sulfonamides
|
|
Concept
|
Cyclooxygenase Inhibitors
|
|
Concept
|
Pyrrolidines
|
|
Concept
|
Bone Morphogenetic Protein 2
|
|
Concept
|
Reactive Oxygen Species
|
|
Concept
|
Intercellular Signaling Peptides and Proteins
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-2
|
|
Concept
|
Receptors, G-Protein-Coupled
|
|
Concept
|
Apoptosis
|
|
Concept
|
Amlodipine
|
|
Concept
|
DNA, Complementary
|
|
Concept
|
Dipeptidyl Peptidase 4
|
|
Concept
|
Hepatitis C Antibodies
|
|
Concept
|
Losartan
|
|
Concept
|
Nitric Oxide Donors
|
|
Concept
|
alpha-Tocopherol
|
|
Concept
|
Xanthine Oxidase
|
|
Concept
|
Cadherins
|
|
Concept
|
Bone Morphogenetic Proteins
|
|
Concept
|
Tissue Inhibitor of Metalloproteinase-2
|
|
Concept
|
Salicylic Acid
|
|
Concept
|
Interleukin-18
|
|
Concept
|
Proteome
|
|
Concept
|
Mitogen-Activated Protein Kinase Kinases
|
|
Concept
|
CD40 Ligand
|
|
Concept
|
STAT3 Transcription Factor
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
Purinergic P2Y Receptor Antagonists
|
|
Concept
|
Receptors, CXCR4
|
|
Concept
|
Protective Agents
|
|
Concept
|
Transforming Growth Factor beta1
|
|
Concept
|
Octamer Transcription Factor-1
|
|
Concept
|
bcl-2-Associated X Protein
|
|
Concept
|
NF-E2-Related Factor 2
|
|
Concept
|
Intercellular Adhesion Molecule-1
|
|
Concept
|
Troponin I
|
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
|
Concept
|
Interleukin-10
|
|
Concept
|
DNA Adducts
|
|
Concept
|
Mitogen-Activated Protein Kinases
|
|
Concept
|
Tocotrienols
|
|
Concept
|
Nitric Oxide Synthase
|
|
Concept
|
11-beta-Hydroxysteroid Dehydrogenases
|
|
Concept
|
Matrix Metalloproteinases
|
|
Concept
|
Antimitotic Agents
|
|
Concept
|
Core Binding Factor Alpha 1 Subunit
|
|
Concept
|
Electron Transport Complex II
|
|
Concept
|
Caspase 3
|
|
Concept
|
Neoplasm Proteins
|
|
Concept
|
Protein Interaction Domains and Motifs
|
|
Concept
|
Matrix Metalloproteinase 1
|
|
Concept
|
Caspase Inhibitors
|
|
Concept
|
Integrin alpha2beta1
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
SOXF Transcription Factors
|
|
Concept
|
Orphan Nuclear Receptors
|
|
Concept
|
Proto-Oncogene Proteins c-bcl-2
|
|
Concept
|
Tissue Inhibitor of Metalloproteinase-1
|
|
Concept
|
Angiotensin II Type 2 Receptor Blockers
|
|
Concept
|
Sirtuin 1
|
|
Concept
|
Caspase 1
|
|
Concept
|
Inflammasomes
|
|
Concept
|
Matrix Metalloproteinase Inhibitors
|
|
Concept
|
Tocopherols
|
|
Concept
|
Oncogene Protein v-akt
|
|
Concept
|
Forkhead Transcription Factors
|
|
Concept
|
Nitric Oxide Synthase Type III
|
|
Concept
|
Thiazolidinediones
|
|
Concept
|
Caspase 8
|
|
Concept
|
rho-Associated Kinases
|
|
Concept
|
Antibodies, Neutralizing
|
|
Concept
|
Transcription Factor RelA
|
|
Concept
|
TOR Serine-Threonine Kinases
|
|
Concept
|
Angiotensin Receptor Antagonists
|
|
Concept
|
Aryldialkylphosphatase
|
|
Concept
|
Immunoglobulins
|
|
Concept
|
Serine Endopeptidases
|
|
Concept
|
Oligonucleotides, Antisense
|
|
Concept
|
Pravastatin
|
|
Concept
|
Lignans
|
|
Concept
|
Protein Isoforms
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Proto-Oncogene Proteins c-akt
|
|
Concept
|
Caspase 9
|
|
Concept
|
Eicosapentaenoic Acid
|
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
|
Concept
|
Cytokines
|
|
Concept
|
Cyclic AMP-Dependent Protein Kinases
|
|
Concept
|
gamma-Tocopherol
|
|
Concept
|
Estrogen Receptor alpha
|
|
Concept
|
p38 Mitogen-Activated Protein Kinases
|
|
Concept
|
Scavenger Receptors, Class A
|
|
Concept
|
NF-kappa B p50 Subunit
|
|
Academic Article
|
LOX-1 deletion limits cardiac angiogenesis in mice given angiotensin II.
|
|
Academic Article
|
DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway.
|
|
Academic Article
|
The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction.
|
|
Academic Article
|
Metabolic Syndrome: Does it Differ Between Women and Men?
|
|
Academic Article
|
Unique Aspects of Coronary Artery Disease in Indian Women.
|
|
Academic Article
|
Women and Heart Disease; A Focus Issue.
|
|
Academic Article
|
Gender-Related Differences in Atherosclerosis.
|
|
Academic Article
|
Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation.
|
|
Academic Article
|
Immunity, Inflammation, and Oxidative Stress in Heart Failure: Emerging Molecular Targets.
|
|
Academic Article
|
Thiamine Therapy for Heart Failure: a Promise or Fiction?
|
|
Academic Article
|
Chronotherapy for hypertension: improvement in patient outcomes with bedtime administration of antihypertensive drugs.
|
|
Academic Article
|
Trends for and Clinical Factors Associated with Choice of Oral P2Y12 Inhibitors for Patients on Chronic Dialysis.
|
|
Academic Article
|
Adverse Cardiovascular Effects of Anti-COVID-19 Drugs.
|
|
Academic Article
|
NF-?B, A Potential Therapeutic Target in Cardiovascular Diseases.
|
|
Academic Article
|
Machine Learning for Predicting Intubations in Heart Failure Patients: the Challenge of the Right Approach.
|